A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
Stopped Strategic business decision was made to terminate the program. There were no safety concerns.
Conditions
Interventions
- DRUG: OnabotulinumtoxinA
- DRUG: Normal Saline
Sponsor
Allergan